Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Debt / NOTE 3.000%12/0
-
Market price (% of par)
-
123.22%
-
Total 13F principal
-
$78,812,692
-
Principal change
-
+$8,071,239
-
Total reported market value
-
$172,027,237
-
Number of holders
-
19
-
Value change
-
+$2,646,808
-
Number of buys
-
4
-
Number of sells
-
12
Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 as of Q3 2016
As of 30 Sep 2016,
ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 was held by
19 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$78,812,692
in principal (par value) of the bond.
The largest 10 bondholders included
Allianz Asset Management GmbH, FMR LLC, GUARDIAN LIFE INSURANCE CO OF AMERICA, WOLVERINE ASSET MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, CREDIT SUISSE AG/, GABELLI FUNDS LLC, OAKTREE CAPITAL MANAGEMENT LP, CNH PARTNERS LLC, and Bank of New York Mellon Corp.
This page lists
19
institutional bondholders reporting positions
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.